Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

MK-462;Maxalt;Maxalt

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 21 USDMF, 13 CEP/COS, 4 JDMF, 15 EU WC, 12 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

27 Drugs in Development

27 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

343 FDF Dossiers, 55 FDA Orange Book, 196 Europe, 41 Canada, 7 Australia, 17 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 6 Rochem International Inc, 19 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 6 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 20 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 46 Disintegrants & Superdisintegrants, 42 Coating Systems & Additives, 34 Direct Compression, 28 Taste Masking, 26 Granulation, 24 Chewable & Orodispersible Aids, 22 Thickeners and Stabilizers, 17 Controlled & Modified Release, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 12 Co-Processed Excipients, 11 Parenteral, 9 Empty Capsules, 5 Rheology Modifiers, 5 Solubilizers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Topical, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 19 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 101 Regulatory FDF Prices

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Alivus Life Sciences	India	ALIVUS LIFE SCIENCES LIMITED Mumbai IN	CEP 2012-108 - Rev 03	Rizatriptan benzoate	2025-04-04	Valid	Chemical		2585
29/11/2025	Apotex Pharmachem	Canada	APOTEX PHARMACHEM INDIA PRIVATE LIMITED Bangalore IN	CEP 2013-206 - Rev 01	Rizatriptan benzoate	2025-09-12	Valid	Chemical		2585

MK-462;Maxalt;Maxalt

MK-462;Maxalt;Maxalt

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

21 USDMF

13 CEP/COS

4 JDMF

15 EU WC

12 NDC API

23 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

27 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

343 FDF Dossiers

55 FDA Orange Book

196 Europe

41 Canada

7 Australia

17 South Africa

27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 10MG BASE

TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem

1 Evonik

6 Rochem International Inc

19 SPI Pharma

7 DKSH

1 Pharm-RX Chemical

4 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

2 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

2 Kirsch Pharma

4 ACG Worldwide

3 Actylis

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

6 BASF

1 Bioplus Life Sciences

11 Corel Pharma Chem

6 DFE Pharma

9 Gangwal Chemicals

4 Ideal Cures

5 Ingredion Pharma Solutions

20 Kerry

4 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

3 Nitika Pharmaceutical Specialities

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

5 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

29 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

4 Silverline Chemicals

1 Symrise

3 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

TABLET;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons